Literature DB >> 17132609

Nonclinical vehicle use in studies by multiple routes in multiple species.

Shayne C Gad1, Crystal D Cassidy, Nicolas Aubert, Bart Spainhour, Heide Robbe.   

Abstract

The laboratory toxicologist is frequently faced with the challenge of selecting appropriate vehicles or developing utilitarian formulations for use in in vivo nonclinical safety assessment studies. Although there are many vehicles available that may meet physical and chemical requirements for chemical or pharmaceutical formulation, there are wide differences in species and route of administration specific to tolerances to these vehicles. In current practice, these differences are largely approached on a basis of individual experience as there is only scattered literature on individual vehicles and no comprehensive treatment or information source. This approach leads to excessive animal use and unplanned delays in testing and development. To address this need, a consulting firm and three contract research organizations conducted a rigorous data mining operation of control (vehicle) data from studies dating from 1991 to present. The results identified 65 single component vehicles used in 368 studies across multiple species (dog, primate, rat, mouse, rabbit, guinea pig, minipig, chick embryo, and cat) by multiple routes. Reported here are the results of this effort, including maximum tolerated use levels by species, route, and duration of study, with accompanying dose limiting toxicity. Also included are basic chemical information and a review of available literature on each vehicle, as well as guidance on volume limits and pH by route and some basic guidance on nonclinical formulation development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132609     DOI: 10.1080/10915810600961531

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  32 in total

1.  Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation.

Authors:  Patricia V Turner; Cynthia Pekow; Mary Ann Vasbinder; Thea Brabb
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.

Authors:  Olga Y Gasheva; Irina Tsoy Nizamutdinova; Laura Hargrove; Cassidy Gobbell; Maria Troyanova-Wood; Sally F Alpini; Sarit Pal; Christina Du; Angie R Hitt; Vlad V Yakovlev; M Karen Newell-Rogers; David C Zawieja; Cynthia J Meininger; Gianfranco D Alpini; Heather Francis; Anatoliy A Gashev
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-26       Impact factor: 4.052

3.  VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir 3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir 3 channels and reduces stress-induced hyperthermia in mice.

Authors:  Baovi N Vo; Kristopher K Abney; Allison Anderson; Ezequiel Marron Fernandez de Velasco; Michael A Benneyworth; John Scott Daniels; Ryan D Morrison; Corey R Hopkins; Charles David Weaver; Kevin Wickman
Journal:  Br J Pharmacol       Date:  2019-05-30       Impact factor: 8.739

4.  Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation.

Authors:  Durgesh Kumar Dwivedi; G B Jena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-31       Impact factor: 3.000

5.  Neurotoxic Outcomes of Subchronic Manganese Chloride Exposure via Contaminated Water in Adult Male Rats and the Potential Benefits of Ebselen.

Authors:  Walaa M El-Hady; Azza A A Galal
Journal:  Biol Trace Elem Res       Date:  2018-03-07       Impact factor: 3.738

6.  Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.

Authors:  Alan R Jacobson; Michael Adler; Nicholas R Silvaggi; Karen N Allen; Genessa M Smith; Ross A Fredenburg; Ross L Stein; Jong-Beak Park; Xiaochuan Feng; Charles B Shoemaker; Sharad S Deshpande; Michael C Goodnough; Carl J Malizio; Eric A Johnson; Sabine Pellett; William H Tepp; Saul Tzipori
Journal:  Toxicon       Date:  2017-07-08       Impact factor: 3.033

7.  The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.

Authors:  Gopinath Kasetty; Ravi K V Bhongir; Praveen Papareddy; Heiko Herwald; Arne Egesten
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

8.  HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes.

Authors:  Christopher Schwake; Michael R Baldwin; William Bachovchin; Shreeya Hegde; James Schiemer; Carolyn Okure; Andrew E Levin; Edouard Vannier; Toshihiko Hanada; Athar H Chishti
Journal:  Biochem Biophys Res Commun       Date:  2019-07-13       Impact factor: 3.575

Review 9.  Neurotoxicity of e-cigarettes.

Authors:  Joanna A Ruszkiewicz; Ziyan Zhang; Filipe Marques Gonçalves; Yousef Tizabi; Judith T Zelikoff; Michael Aschner
Journal:  Food Chem Toxicol       Date:  2020-03-05       Impact factor: 6.023

10.  Vehicle-dependent disposition kinetics of fluoranthene in Fisher-344 rats.

Authors:  Deacqunita L Harris; Darry B Hood; Aramandla Ramesh
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.